2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   5

Issue No. :  8

Year :  2012

Pages :   1025-1033

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Benzopyran-4-one is an Ideal Pharmacophore for Lead Optimization in Antidiabetic Drug Discovery



Address:   Yogendra Nayak1*, Jayashree B.S.2, Unnikrishnan M.K.3
1Dept of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka – 576104, India
2Dept of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka – 576104, India
3Dept of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka – 576104, India
*Corresponding Author
DOI No: Not Available

ABSTRACT:
Diabetes mellitus (DM) is a metabolic disorder associated with retinopathy, nephropathy, cardiomyopathy, peripheral neuropathy and autonomic neuropathies leading to gastrointestinal, genitourinary, cardiovascular complications and sexual dysfunction. The present available antidiabetic agents are not interferingin the modulation of these complications. Benzopyran-4-one is the basic moiety present in naturally occurring flavonoids. Number of flavonoids hasbeen found to be antidiabetic and many of themmodulate diabetes related complications by acting on newer targets. Hence, an attempt was made to review the possibilities of modulating benzopyran-4-one scaffold for lead optimization in antidiabetic drug discovery.
KEYWORDS:
Diabetes mellitus, benzopyran-4-one, flavonoids, antidiabetic, lead optimization.
Cite:
Yogendra Nayak, Jayashree B.S., Unnikrishnan M.K. Benzopyran-4-one is an Ideal Pharmacophore for Lead Optimization in Antidiabetic Drug Discovery. Research J. Pharm. and Tech. 5(8): August 2012; Page 1025-1033.
[View HTML]      [View PDF]



Visitor's No. :   643287